Evelyn Lopez-Brignoni, M.D.
1 extracted findings · 1 model-assigned issue type
FDA source excerpt, selected passage
Based on our investigation, four out (b)(4) subjects randomized into Protocol (b)(4) took less than the required (b)(4). As a result, subjects may have taken (1) placebo only rather than the required study drug, or (2) less than the full intended dose of study drug.
Findings and supporting evidence
Model-assisted readings, not an exhaustive interpretation. Compare with the extracted source findings below.
Subjects in Protocol (b)(4) took less than the required study medication, potentially receiving placebo only or reduced dose.
Supporting FDA text
Source excerpt · automated text-match checkBased on our investigation, four out (b)(4) subjects randomized into Protocol (b)(4) took less than the required (b)(4). As a result, subjects may have taken (1) placebo only rather than the required study drug, or (2) less than the full intended dose of study drug.
Subjects in Protocol (b)(4) received less than the required study medication, potentially receiving placebo only.
Supporting FDA text
Source excerpt · automated text-match checkBased on our investigation, nine out (b)(4) randomized subjects in Protocol (b)(4) received less than the required (b)(4). As a result, some subjects may have taken placebo only rather than the required study drug.
Findings extracted from the letter
Selected FDA passages, not the complete letter.
Source passage selected by the model
What FDA requested
Model-assisted summary. Consult the letter for complete requests and conditions.
- Specify the corrective actions you, as a clinical investigator, have taken to prevent similar violations in the future.
Sections and clauses cited
As cited in this historical letter, not a statement of current regulatory requirements.